GARDASIL 9 (Merck Sharp & Dohme Corp.)
Welcome to the PulseAid listing for the GARDASIL 9 drug offered from Merck Sharp & Dohme Corp.. This Inactivated Human Papillomavirus Vaccine [EPC],Actively Acquired Immunity [PE],Papillomavirus Vaccines [Chemical/Ingredient],Vaccines, Inactivated [Chemical/Ingredient],Inactivated Human Papillomavirus Vaccine [EPC],Actively Acquired Immunity [PE],Papillomavirus Vaccines [Chemical/Ingredient],Vaccines, Inactivated [Chemical/Ingredient],Inactivated Human Papillomavirus Vaccine [EPC],Actively Acquired Immunity [PE],Papillomavirus Vaccines [Chemical/Ingredient],Vaccines, Inactivated [Chemical/Ingredient],Inactivated Human Papillomavirus Vaccine [EPC],Actively Acquired Immunity [PE],Papillomavirus Vaccines [Chemical/Ingredient],Vaccines, Inactivated [Chemical/Ingredient] pharmaceutical is classified as a VACCINE. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same VACCINE drug type category.
LABELER NAME / MANUFACTURER: | Merck Sharp & Dohme Corp. |
NON-PROPRIETARY NAME: | Human Papillomavirus 9-valent Vaccine, Recombinant |
SUBSTANCE NAME: | HUMAN PAPILLOMAVIRUS TYPE 6 L1 CAPSID PROTEIN ANTIGEN; HUMAN PAPILLOMAVIRUS TYPE 11 L1 CAPSID PROTEIN ANTIGEN; HUMAN PAPILLOMAVIRUS TYPE 16 L1 CAPSID PROTEIN ANTIGEN; HUMAN PAPILLOMAVIRUS TYPE 18 L1 C |
TYPE: | VACCINE |
PHARMA CLASS: | Inactivated Human Papillomavirus Vaccine [EPC],Actively Acquired Immunity [PE],Papillomavirus Vaccines [Chemical/Ingredient],Vaccines, Inactivated [Chemical/Ingredient],Inactivated Human Papillomavirus Vaccine [EPC],Actively Acquired Immunity [PE],Papillomavirus Vaccines [Chemical/Ingredient],Vaccines, Inactivated [Chemical/Ingredient],Inactivated Human Papillomavirus Vaccine [EPC],Actively Acquired Immunity [PE],Papillomavirus Vaccines [Chemical/Ingredient],Vaccines, Inactivated [Chemical/Ingredient],Inactivated Human Papillomavirus Vaccine [EPC],Actively Acquired Immunity [PE],Papillomavirus Vaccines [Chemical/Ingredient],Vaccines, Inactivated [Chemical/Ingredient] |
ROUTE: | INTRAMUSCULAR |
DOSAGE FORM: | INJECTION, SUSPENSION |
MARKETING CATEGORY NAME: | BLA |
START MARKETING DATE: | 2014-12-10 |
END MARKETING DATE: | 0000-00-00 |
GARDASIL 9 VACCINE Details:
Item Description | GARDASIL 9 from Merck Sharp & Dohme Corp. |
LABELER NAME: | Merck Sharp & Dohme Corp. |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 30; 40; 60; 40; 20; 20; 20; 20; 20(ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL) |
START MARKETING DATE: | 2014-12-10 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 0006-4119_f9b68e8e-3842-4a15-be21-b500db14b5dd |
PRODUCT NDC: | 0006-4119 |
APPLICATION NUMBER: | BLA125508 |
Other HUMAN PAPILLOMAVIRUS TYPE 6 L1 CAPSID PROTEIN ANTIGEN; HUMAN PAPILLOMAVIRUS TYPE 11 L1 CAPSID PROTEIN ANTIGEN; HUMAN PAPILLOMAVIRUS TYPE 16 L1 CAPSID PROTEIN ANTIGEN; HUMAN PAPILLOMAVIRUS TYPE 18 L1 C Pharmaceutical Manufacturers / Labelers: